Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | STTK |
---|---|---|
09:32 ET | 13270 | 8.15 |
09:34 ET | 186 | 7.9709 |
09:36 ET | 2570 | 8.05 |
09:38 ET | 300 | 8.04 |
09:39 ET | 200 | 7.975 |
09:41 ET | 11155 | 7.85 |
09:43 ET | 800 | 7.97 |
09:45 ET | 300 | 7.97 |
09:48 ET | 1404 | 8.04 |
09:50 ET | 572 | 8.03 |
09:52 ET | 300 | 8.03 |
09:54 ET | 200 | 8.03 |
09:56 ET | 599 | 7.92 |
09:59 ET | 600 | 7.85 |
10:03 ET | 11414 | 7.7 |
10:12 ET | 600 | 7.62 |
10:15 ET | 1772 | 7.64 |
10:17 ET | 100 | 7.72 |
10:19 ET | 439 | 7.81 |
10:28 ET | 700 | 7.73 |
10:32 ET | 600 | 7.7 |
10:33 ET | 850 | 7.6999 |
10:35 ET | 13221 | 7.6 |
10:37 ET | 100 | 7.7 |
10:44 ET | 1951 | 7.7162 |
10:48 ET | 1599 | 7.67 |
10:50 ET | 1669 | 7.78 |
10:55 ET | 1418 | 7.8 |
10:57 ET | 100 | 7.85 |
11:02 ET | 1200 | 7.9 |
11:06 ET | 600 | 7.84 |
11:09 ET | 300 | 7.93 |
11:11 ET | 400 | 7.93 |
11:15 ET | 906 | 7.89 |
11:18 ET | 200 | 7.92 |
11:22 ET | 100 | 7.98 |
11:26 ET | 300 | 7.99 |
11:27 ET | 3849 | 7.95 |
11:29 ET | 200 | 7.925 |
11:31 ET | 1300 | 7.875 |
11:33 ET | 100 | 7.86 |
11:36 ET | 706 | 7.86 |
11:38 ET | 300 | 7.845 |
11:42 ET | 500 | 7.88 |
11:44 ET | 1600 | 7.855 |
11:45 ET | 700 | 7.845 |
11:47 ET | 600 | 7.78 |
11:49 ET | 617 | 7.765 |
11:51 ET | 300 | 7.75 |
11:54 ET | 555 | 7.8 |
11:56 ET | 100 | 7.78 |
12:02 ET | 100 | 7.8 |
12:05 ET | 700 | 7.8 |
12:07 ET | 100 | 7.78 |
12:09 ET | 1200 | 7.81 |
12:12 ET | 100 | 7.81 |
12:14 ET | 200 | 7.81 |
12:16 ET | 800 | 7.81 |
12:18 ET | 100 | 7.81 |
12:21 ET | 100 | 7.81 |
12:23 ET | 100 | 7.81 |
12:25 ET | 328 | 7.81 |
12:27 ET | 900 | 7.75 |
12:30 ET | 250 | 7.715 |
12:32 ET | 500 | 7.77 |
12:36 ET | 12960 | 7.72 |
12:38 ET | 300 | 7.72 |
12:39 ET | 300 | 7.75 |
12:41 ET | 1048 | 7.756 |
12:43 ET | 1060 | 7.74 |
12:45 ET | 700 | 7.73 |
12:48 ET | 100 | 7.72 |
12:54 ET | 255 | 7.75 |
12:57 ET | 200 | 7.75 |
01:01 ET | 2200 | 7.71 |
01:10 ET | 1429 | 7.696 |
01:12 ET | 200 | 7.68 |
01:15 ET | 100 | 7.68 |
01:19 ET | 1966 | 7.71 |
01:21 ET | 1700 | 7.66 |
01:28 ET | 128 | 7.655 |
01:32 ET | 147 | 7.655 |
01:35 ET | 220 | 7.655 |
01:37 ET | 106 | 7.6775 |
01:44 ET | 2732 | 7.68 |
01:46 ET | 949 | 7.68 |
01:48 ET | 861 | 7.7 |
01:50 ET | 100 | 7.7 |
01:51 ET | 400 | 7.71 |
01:55 ET | 100 | 7.72 |
01:57 ET | 100 | 7.74 |
02:00 ET | 2700 | 7.75 |
02:02 ET | 26611 | 7.78 |
02:04 ET | 1634 | 7.84 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Shattuck Labs Inc | 376.4M | -4.1x | --- |
Fibrobiologics Inc | 371.4M | -12.1x | --- |
Terns Pharmaceuticals Inc | 381.6M | -5.0x | --- |
Q32 Bio Inc | 362.6M | -1.2x | --- |
Nautilus Biotechnology Inc | 369.5M | -5.3x | --- |
Anavex Life Sciences Corp | 385.1M | -9.0x | --- |
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $376.4M |
---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.86 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 138.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.